Regress Lifesciences Private Limited - Company Profile

It is a pharma private limited company based in Delhi, Delhi, India, established in 2006.
2006 Delhi, Delhi, India Active
Last Updated:
About Regress Lifesciences Private Limited

Regress Lifesciences Private Limited, a active private limited company, was established on 24 August 2006 in Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U85121DL2006PTC152439. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Sangeeta Billa (Director), Arvind Billa (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at N-101, N Block, Anupam Apartments East Arjun Nagar, Delhi, Delhi, 110032.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85121DL2006PTC152439

  • Registration Number

    152439

  • Incorporation Date

    24 August 2006

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 19 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** %
  • Profit Growth **** 98.21%
  • Ebitda **** 98.21%
  • Net Worth -1.83%
  • Total Assets -1.83%
Company report

Regress Lifesciences Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Regress Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Regress Lifesciences Private Limited?
Current Directors
Name Designation Appointment Date Status
Sangeeta Billa Director 24 Aug 2006 Current
Arvind Billa Director 24 Aug 2006 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Regress Lifesciences.

Regress Lifesciences Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 98.21% increase in profit. The company's net worth dipped by a decrease of 1.83%.

Regress Lifesciences revenue growth over time
Regress Lifesciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
-1.83%
*******
*******
*******
*******
Profit or Loss
*******
98.21%
*******
*******
*******
*******
Net Worth
*******
-1.83%
*******
*******
*******
*******
EBITDA
*******
98.21%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Regress Lifesciences?

In 2021, Regress Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Regress Lifesciences?

Unlock and access historical data on people associated with Regress Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Regress Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Regress Lifesciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Regress Lifesciences
Recent Activity within the Organization
  • Annual General Meeting

    Regress Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Regress Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was completed.

  • Director Appointment

    Sangeeta Billa was appointed as a Director was appointed as a Director on 24 Aug 2006 & has been associated with this company since 19 years 6 months . was recorded as a recent event.

  • Director Appointment

    Arvind Billa was appointed as a Director was appointed as a Director on 24 Aug 2006 & has been associated with this company since 19 years 6 months . was recorded as a recent event.

  • Company Incorporation

    The activity Regress Lifesciences Private Limited was registered on 24 Aug 2006 with Roc Delhi & aged 19 years 6 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Regress Lifesciences Private Limited?

The CIN of Regress Lifesciences Private Limited is U85121DL2006PTC152439.

Where is Regress Lifesciences Private Limited headquartered?

Regress Lifesciences Private Limited is headquartered at N-101, N Block, Anupam Apartments East Arjun Nagar, Delhi, Delhi, 110032.

When was Regress Lifesciences Private Limited incorporated?

Regress Lifesciences Private Limited was incorporated on 24 August 2006.

Who are the current directors of Regress Lifesciences Private Limited?

The current directors of Regress Lifesciences Private Limited are

What is the primary industry of Regress Lifesciences Private Limited?

The primary industry of Regress Lifesciences Private Limited is Pharma.

Is Regress Lifesciences Private Limited a listed company?

Regress Lifesciences Private Limited is unlisted.

What is the capital structure of Regress Lifesciences Private Limited?

The authorized capital of Regress Lifesciences Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Regress Lifesciences Private Limited?

The compliance status of Regress Lifesciences Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available